Form 13-F position report

ETON PHARMACEUTICALS INC

Reported by Acuitas Investments LLC

ETON CUSIP 29772L108 Manager CIK 0001524828

Reported 510,054 shares, up 41,367 (8.8%) from the prior quarter.

Reported value -1.3%; share count 8.8% vs. the prior quarter.

Added
% of reported 13F value 1.04% This manager · Q2 2023
Shares 510,054 Quarter-end amount reported
Reported value $1,780,088 Fair value at quarter end
Consecutive quarters held 2 Through Q2 2023

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2023-03-31 1804445
2023-06-30 1780088
2023-09-30 913230
2023-12-31 2155197
2024-03-31 2174850
2024-06-30 1908068
2024-09-30 3479760
2024-12-31 2475176
2025-03-31 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

9 quarters
Quarterly reported position history for ETON PHARMACEUTICALS INC held by Acuitas Investments LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q1 2025 Reduced 0 -185,824 (-100.0%) 0 $0 2025-04-28
Q4 2024 Reduced 185,824 -394,136 (-68.0%) 2.03% $2,475,176 2025-01-31
Q3 2024 Unchanged 579,960 0 (0.0%) 1.55% $3,479,760 2024-11-07
Q2 2024 Unchanged 579,960 0 (0.0%) 1.02% $1,908,068 2024-08-05
Q1 2024 Added 579,960 +87,906 (17.9%) 1.1% $2,174,850 2024-05-10
Q4 2023 Added 492,054 +273,054 (124.7%) 1.13% $2,155,197 2024-02-02
Q3 2023 Reduced 219,000 -291,054 (-57.1%) 0.54% $913,230 2023-10-27
Q2 2023 Added 510,054 +41,367 (8.8%) 1.04% $1,780,088 2023-08-07
Q1 2023 New 468,687 +468,687 (0.0%) 1.86% $1,804,445 2023-05-02

Who else reported the position

40 managers reported ETON PHARMACEUTICALS INC for Q2 2023.

Managers reporting ETON PHARMACEUTICALS INC in Q2 2023.
Manager Activity Shares Change % of reported 13F Reported value Tenure
Opaleye Management Inc Added 2,285,000 +100,000 1.91% $7,974,650 19 qtrs
VANGUARD GROUP INC Reduced 976,436 -3,847 < 0.01% $3,407,762 18 qtrs
Westside Investment Management Inc Added 519,251 +1,950 0.51% $1,812,202 14 qtrs
Acuitas Investments LLC This report Added 510,054 +41,367 1.04% $1,780,088 2 qtrs
PARADIGM CAPITAL MANAGEMENT INC NY Unchanged 300,000 0 0.06% $1,047,000 7 qtrs
BlackRock Inc Added 298,225 +5,560 < 0.01% $1,040,807 19 qtrs
BRIDGEWAY CAPITAL MANAGEMENT LLC Unchanged 241,462 0 0.02% $842,702 10 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 210,092 +23,510 < 0.01% $733,221 13 qtrs
AWM Investment Company Inc Unchanged 158,676 0 0.08% $553,779 19 qtrs
THE BANK OF NEW YORK MELLON CORPORATION Unchanged 79,402 0 < 0.01% $277,113 13 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2023
Filed
August 07, 2023
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
0
Shared
510,054
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.